2000 Vol.18, N°4 - Suppl.20 - Table of contents

First International Conference on Polymyalgia Rheumatica/Giant Cell Arteritis

Guest Editors: F. Cantini, G.G. Hunder, I. Olivieri, C. Salvarani

Introduction

CER1678
2000,18,4,Suppl.20
Pg. 0001

Free to view

Introductory comment regarding the GCA/PMR conference
G.G. Hunder

Full Papers

CER1679
2000,18,4,Suppl.20
Pg. 0001-0003

Free to view

The history of polymyalgia rheumatica/giant cell arteritis
I. Portioli

CER1680
2000,18,4,Suppl.20
Pg. 0004-0005

Free to view

Classification/diagnostic criteria for GCA/PMR
G.G. Hunder

CER1681
2000,18,4,Suppl.20
Pg. 0006-0008

Free to view

Clinical features of GCA/PMR
G.G. Hunder

CER1682
2000,18,4,Suppl.20
Pg. 0009-0011

Free to view

Epidemiology of polymyalgia rheumatica
M.A. Cimmino, A. Zaccaria

CER1683
2000,18,4,Suppl.20
Pg. 0012-0014

Free to view

Human Parvovirus and giant cell arteritis: A selective arteritic impact ?
H. Elling, A.T. Olsson, P. Elling

CER1684
2000,18,4,Suppl.20
Pg. 0015-0017

Free to view

Epidemiology of biopsy-positive giant cell arteritis: An overview
E. Nordberg

CER1685
2000,18,4,Suppl.20
Pg. 0018-0021

Free to view

The pathogenesis of giant cell arteritis: Morphological aspects
C. Nordborg, E. Nordborg, V. Petursdottir

CER1686
2000,18,4,Suppl.20
Pg. 0022-0023

Free to view

Giant cell arteritis and polymyalgia rheumatica: Role of viral infections
P. Duhaut, S. Bosshard, C. Dumontet

CER1687
2000,18,4,Suppl.20
Pg. 0024-0026

Free to view

Neurologic manifestations of giant cell arteritis
G. Nesher

CER1688
2000,18,4,Suppl.20
Pg. 0027-0028

Free to view

Giant cell arteritis as a cause of death
R. Andersson

CER1689
2000,18,4,Suppl.20
Pg. 0029-0031

Free to view

Laboratory investigations useful in the evaluation of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA)
B. Hazleman

CER1690
2000,18,4,Suppl.20
Pg. 0032-0033

Free to view

Von Willebrand factor in polymyalgia rheumatica and giant cell arteritis
A.C. Uddhammar

CER1691
2000,18,4,Suppl.20
Pg. 0034-0037

Free to view

Polymyalgia rheumatica with normal erythrocyte sedimentation rate: Clinical aspects
V.M. Martínez-Taboada, R. Blanco, V. Rodríguez-Valverde

CER1692
2000,18,4,Suppl.20
Pg. 0038-0039

Free to view

Magnetic resonance imaging in the diagnosis of polymyalgia rheumatica
P. Pavlica, L. Barozzi, C. Salvarani, F. Cantini, I. Olivieri

CER1693
2000,18,4,Suppl.20
Pg. 0040-0042

Free to view

Doppler ultrasonography in the diagnosis of giant cell arteritis
W.A. Schmidt

CER1694
2000,18,4,Suppl.20
Pg. 0043-0048

Free to view

Imaging findings in extracranial (giant cell) temporal arteritis
A.W. Stanson

CER1695
2000,18,4,Suppl.20
Pg. 0049-0050

Free to view

Elderly onset rheumatoid arthritis: Clinical aspects
G. Bajocchi, R. La Corte, A. Locaputo, M. Govoni, F. Trotta

CER1696
2000,18,4,Suppl.20
Pg. 0051-0052

Free to view

Distal musculoskeletal manifestations in polymyalgia rheumatica
C. Salvarani, F. Cantini, I. Olivieri

CER1697
2000,18,4,Suppl.20
Pg. 0053-0055

Free to view

RS3PE syndrome: An overview
I. Olivieri, C. Salvarani, F. Cantini

CER1698
2000,18,4,Suppl.20
Pg. 0056-0057

Free to view

Corticosteroids in polymyalgia rheumatica - A review of different treatment schedules
C. Li, B. Dasgupta

CER1699
2000,18,4,Suppl.20
Pg. 0058-0060

Free to view

Steroid sparing therapeutic approaches to polymyalgia rheumatica-giant cell arteritis. State of the art and perspectives
G.F. Ferraccioli, E. Di Poi, R. Damato

CER1700
2000,18,4,Suppl.20
Pg. 0061-0063

Free to view

Prevention of serious ophthalmic and cerebral complications in temporal arteritis ?
D. Schmidt, P. Vaith, A. Hetzel

CER1701
2000,18,4,Suppl.20
Pg. 0064-0066

Free to view

Corticosteroid-induced osteoporosis: Pathogenesis and prevention
S. Benvenuti, M.L. Brandi